BR112017012021A2 - um processo para a fabricação de idalopirdina - Google Patents
um processo para a fabricação de idalopirdinaInfo
- Publication number
- BR112017012021A2 BR112017012021A2 BR112017012021A BR112017012021A BR112017012021A2 BR 112017012021 A2 BR112017012021 A2 BR 112017012021A2 BR 112017012021 A BR112017012021 A BR 112017012021A BR 112017012021 A BR112017012021 A BR 112017012021A BR 112017012021 A2 BR112017012021 A2 BR 112017012021A2
- Authority
- BR
- Brazil
- Prior art keywords
- idalopirdine
- manufacture
- preparation
- disclosed
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
é revelado no presente documento um processo para a preparação de idalopirdina e sais farmaceuticamente aceitáveis da mesma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201400721 | 2014-12-12 | ||
PCT/EP2015/079209 WO2016091997A1 (en) | 2014-12-12 | 2015-12-10 | A process for the manufacture of idalopirdine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017012021A2 true BR112017012021A2 (pt) | 2018-03-13 |
Family
ID=59011415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017012021A BR112017012021A2 (pt) | 2014-12-12 | 2015-12-10 | um processo para a fabricação de idalopirdina |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3230265A1 (pt) |
JP (1) | JP2017537128A (pt) |
KR (1) | KR20170093821A (pt) |
CN (1) | CN107001266A (pt) |
AU (1) | AU2015359347A1 (pt) |
BR (1) | BR112017012021A2 (pt) |
CA (1) | CA2968770A1 (pt) |
CL (1) | CL2017001466A1 (pt) |
CO (1) | CO2017005357A2 (pt) |
IL (1) | IL252471A0 (pt) |
MA (1) | MA41148A (pt) |
MX (1) | MX2017007510A (pt) |
RU (1) | RU2017120216A (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3231793T1 (sl) | 2014-12-12 | 2020-07-31 | Japan Tobacco Inc. | Spojine dihidropirimidin-2-ona in njihove medicinske uporabe |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3042685A (en) * | 1962-07-03 | Process of making g-fluoro tryptamine | ||
AR065804A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
TW201139370A (en) * | 2009-12-23 | 2011-11-16 | Lundbeck & Co As H | Processes for the manufacture of a pharmaceutically active agent |
-
2015
- 2015-12-09 MA MA041148A patent/MA41148A/fr unknown
- 2015-12-10 CN CN201580065028.6A patent/CN107001266A/zh active Pending
- 2015-12-10 MX MX2017007510A patent/MX2017007510A/es unknown
- 2015-12-10 AU AU2015359347A patent/AU2015359347A1/en not_active Abandoned
- 2015-12-10 EP EP15821029.4A patent/EP3230265A1/en not_active Withdrawn
- 2015-12-10 KR KR1020177015206A patent/KR20170093821A/ko unknown
- 2015-12-10 BR BR112017012021A patent/BR112017012021A2/pt not_active Application Discontinuation
- 2015-12-10 RU RU2017120216A patent/RU2017120216A/ru not_active Application Discontinuation
- 2015-12-10 JP JP2017531139A patent/JP2017537128A/ja active Pending
- 2015-12-10 CA CA2968770A patent/CA2968770A1/en not_active Abandoned
-
2017
- 2017-05-23 IL IL252471A patent/IL252471A0/en unknown
- 2017-05-26 CO CONC2017/0005357A patent/CO2017005357A2/es unknown
- 2017-06-08 CL CL2017001466A patent/CL2017001466A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3230265A1 (en) | 2017-10-18 |
AU2015359347A1 (en) | 2017-06-08 |
MX2017007510A (es) | 2017-08-22 |
MA41148A (fr) | 2017-10-17 |
CN107001266A (zh) | 2017-08-01 |
KR20170093821A (ko) | 2017-08-16 |
CO2017005357A2 (es) | 2017-09-20 |
JP2017537128A (ja) | 2017-12-14 |
CL2017001466A1 (es) | 2018-01-05 |
IL252471A0 (en) | 2017-07-31 |
CA2968770A1 (en) | 2016-06-16 |
RU2017120216A (ru) | 2019-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2022046I1 (no) | Berotralstat and pharmaceutically acceptable salts thereof | |
NL301217I2 (nl) | tirzepatide en farmaceutisch aanvaardbare zouten daarvan | |
NL301286I2 (nl) | Danicopan, of een farmaceutisch aanvaardbaar zout ervan | |
NL301128I2 (nl) | Risdiplam of een farmaceutisch aanvaardbaar zout daarvan | |
NL301111I2 (nl) | Entrectinib of een farmaceutisch aanvaardbaar zout daarvan | |
BR112016021834A2 (pt) | Copolímero de propileno heteroplástico, processo para preparação de um copolímero de propileno heteroplástico, e, artigo | |
DK3191502T3 (da) | Målrettet indgivelse af tertiært aminholdige lægemiddelstoffer | |
DK3750545T3 (da) | Phospholipidetheranaloger som cancermålrettede lægemiddelbærere | |
BR102015017380A2 (pt) | dispositivo para a reticulação do tecido do olho, e, composição farmacêutica | |
IN2014CH00247A (pt) | ||
CO2017003955A2 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
DK3203834T3 (da) | Hovbehandlingsarrangement | |
NO2022058I1 (no) | Capmatinib or a pharmaceutically acceptable salt thereof | |
BR112016022219A2 (pt) | formulações farmacêuticas de um inibidor de quinase pan-raf, processos para preparação da mesma e métodos de utilização | |
CY1121464T1 (el) | Στεροειδης ενωση για χρηση στην αντιμετωπιση της ηπατικης εγκεφαλοπαθειας | |
DK2897382T3 (da) | Forbedring af binaural kilde | |
BR112017014085A2 (pt) | processos para a preparação de hemifumarato de tenofovir alafenamida amorfo e uma pré-mistura do mesmo | |
EP3324958A4 (en) | Salts and prodrugs of 1-methyl-d-tryptophan | |
ES2816202T8 (es) | Procedimiento para producir una prótesis o una prótesis parcial | |
BR112016028083A2 (pt) | Composição oral farmacêutica de isotretinoina e seu processo de preparação | |
EP3092217A4 (en) | A novel process for preparation of indacaterol or its pharmaceutically acceptable salts | |
IN2013MU01111A (pt) | ||
ITUA20162283A1 (it) | Tonometro indossabile perfezionato | |
BR112017012021A2 (pt) | um processo para a fabricação de idalopirdina | |
BR112016028698A2 (pt) | preparação de piperidina-4-carbotioamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |